PGA star Fred Couples credits Regenokine with keeping him on the golf course despite his severe arthritic back pain. It is a new treatment that uses beneficial proteins collected from your own blood to treat pain and inflammation in the joints.
It’s similar to PRP therapy but works better and lasts longer. The procedure has been approved in Germany and is used off-label in the US by physicians licensed by Wehling.
A blood therapy called Regenokine (or Orthokine, a rebranding of an old treatment known as IRAP) targets a protein in your body that triggers inflammation and pain. It works by processing your own blood to concentrate anti-inflammatory proteins and growth factors that can help your injured tissues heal faster. It’s similar to platelet-rich plasma (PRP), but more powerful and doesn’t need stem cells.
The procedure can be used on almost all joints, spinal structures, ligaments, muscles and tendons. It can reduce joint inflammation, improve mobility and prevent cartilage damage in patients with osteoarthritis. Small studies have shown it can postpone the need for knee replacement surgery in some patients. The treatment is also popular with professional athletes, including Seattle Seahawks Michael Bennett, Cliff Avril and Tyler Lockett.
Regenokine, also known as orthokine and autologous conditioned serum, is a non-surgical treatment that uses the body’s own anti-inflammatory proteins and growth factors to help heal injured joints. It can reduce pain, inflammation and increase mobility.
The procedure is similar to platelet-rich plasma (PRP) therapy. Doctors take a sample of blood from your arm and slightly heat it to separate out the healing proteins.
This is then injected into the injured joint. The resulting serum is free of white and red blood cells which can cause irritation.
It is believed that the serum contains a protein that blocks interleukin-1, a substance that causes inflammation and joint destruction. This is what has attracted sports stars such as Kobe Bryant and Alex Rodriguez to travel to Germany to have the treatment.
Developed by spinal surgeon Peter Wehling, Regenokine is an updated version of Orthokine. Like PRP therapy, it involves a blood draw and incubation with zinc etched glass beads. Unlike PRP, it doesn’t concentrate platelets or contain stem cells. Instead it focuses on a protein called IRAP which can stop interleukin-1, the enzyme that causes inflammation and arthritis.
The resulting yellowish serum contains proteins that fight inflammation and block pain. It is then injected into the joint.
The treatment has been proven to be effective in clinical trials. Athletes such as Kobe Bryant and Alex Rodriguez have traveled to Wehling’s clinic in Germany to receive it. However, it is not approved by the FDA. It’s also more expensive than PRP or stem cell treatments, which may be the reason why it hasn’t been widely used.
The Regenokine procedure at Los Angeles Pain Relief Clinic uses a patient’s own blood to concentrate beneficial proteins that fight inflammation and promote regeneration. It’s similar to platelet-rich plasma (PRP) therapy but stronger and more effective. It hasn’t been FDA-approved but is used off-label at three sites in the United States licensed by Wehling.
During the process, blood is drawn from your body through syringes and then treated with heat to separate the growth factors that can help reduce inflammation and speed healing. It’s a variation of a treatment called Orthokine, which was developed by spinal surgeon Peter Wehling.
The treatments have potential to elevate chronic pain, osteoarthritis and fibromyalgia by reducing inflammation. Many professional athletes like Kobe Bryant, Lindsey Berg and Alex Rodriguez have already reported incredible results. The treatment can be done in your home, and the recovery is much faster than surgery.
Also known as autologous conditioned serum (ACS) in Europe and Regenokine in the US, the treatment uses your own blood to fight pain. It involves drawing a sample, processing it to increase the concentration of anti-inflammatory platelets and then reinjecting it into the joint.
It works by blocking interleukin 1, a protein that triggers inflammation and can speed up arthritic cartilage and tissue breakdown. It’s been shown to relieve pain and may postpone or even avoid surgery in some people.
It is similar to PRP therapy, which draws blood and incubates it with zinc etched glass beads to concentrate platelets that can boost healing and repair tissues. But whereas PRP doesn’t contain stem cells, Regenokine does. It may also help regenerate cartilage and other damaged tissue.